Results 11 to 20 of about 86,474 (255)

The molecular mechanisms linking metabolic syndrome to endometrial and breast cancers

open access: yesJournal of Mind and Medical Sciences, 2021
The metabolic syndrome represents a plethora of cardio-metabolic risk factors including obesity, arterial hypertension, atherogenic dyslipidemia, hyperglycemia, accompanied by pro-inflammatory and pro-thrombotic state.
Andrada-Luciana Lazar   +9 more
doaj   +1 more source

Predictive Utility of Systemic Immune Inflammation Index (SII) in Identifying Endometrial Carcinoma in Premalignant Endometrial Lesions

open access: yesVan Tıp Dergisi, 2023
INTRODUCTION: It is important to detect endometrial cancer (EC) in endometrial intraepithelial neoplasia (EIN) patients. It was aimed to determine the role of systemic immune inflammation index (SII) in predicting concurrent EC in women with EIN. METHODS:
Caner Köse   +5 more
doaj   +1 more source

Primary endometrial B-Cell lymphoma: Rare etiology of abnormal uterine bleeding and potential nonsurgical therapy

open access: yesRadiology Case Reports, 2015
We present a case of primary endometrial B-cell lymphoma, pathologically confirmed. The patient is a 68-year-old female with postmenopausal bleeding. Ultrasound revealed endometrial thickening and was followed up with endometrial biopsy.
Jonathan Revels, DO   +2 more
doaj   +1 more source

Endometrial cancer - reduce to the minimum. A new paradigm for adjuvant treatments?

open access: yesRadiation Oncology, 2011
Background Up to now, the role of adjuvant radiation therapy and the extent of lymph node dissection for early stage endometrial cancer are controversial.
Scheithauer Heike R   +2 more
doaj   +1 more source

Molecular Profiling of Endometrial Malignancies

open access: yesObstetrics and Gynecology International, 2010
Molecular profiling of endometrial neoplasms reveals genetic changes in endometrial carcinomas that support the dualistic model, in which type I carcinomas are estrogen-dependent, low grade lesions and type II carcinomas are nonestrogen dependent and ...
Norasate Samarnthai   +2 more
doaj   +1 more source

Synchronous Occurrence of Primary Neoplasms in the Uterus with Squamous Cell Carcinoma of the Cervix and Adenocarcinoma of the Endometrium

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2006
Objective: Synchronous primary malignant neoplasms of the uterus are uncommon. Patients with synchronous cervical and endometrial cancers are even rarer.
Cheng-Kuo Lin   +3 more
doaj   +1 more source

Study of ER, PR and VEGF Expression in Endometrial Epithelial Neoplasms and its Association with Histological Stage and Grade of Endometrial Carcinoma [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2022
Introduction: Exogenous or endogenous oestrogen induces hyperplastic endometrium which presents with abnormal uterine bleeding. Atypical endometrial hyperplasia is the precursor for endometrial carcinoma. In case of invasive carcinoma, oestrogen Receptor
SK Samim Rahaman   +3 more
doaj   +1 more source

Concurrent endometrial intraepithelial carcinoma (EIC) and endometrial hyperplasia

open access: yesHuman Pathology: Case Reports, 2015
Endometrial cancer is one of the most common gynecological neoplasms in the United States. It is divided into type I and type II carcinomas based on histological features.
Steven Wang, MD   +2 more
doaj   +1 more source

Endometrial Stromal Hyperplasia: An Underrecognized Condition

open access: yesCase Reports in Pathology, 2013
Hyperplasia of the endometrial stroma is a poorly recognized lesion, lacking widespread recognition with most, if not all, such cases sequestrated in the literature as endometrial stromal nodules or low-grade endometrial stromal sarcomas.
Efthimios Sivridis   +2 more
doaj   +1 more source

Lifestyle advice to reduce ovarian cancer risk [PDF]

open access: yesWorld Cancer Research Journal, 2020
OBJECTIVE: Ovarian cancer is usually diagnosed at advanced stages; it has one of the worst prognoses among gynecologic neoplasms and it hasn’t got an effective screening program. It has modifiable risk factors in common with endometrial and breast cancer.
L. Del Pup, L. Driul, F. Peccatori
doaj   +1 more source

Home - About - Disclaimer - Privacy